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ICOS-L and B7-H1.
Background. Renal tubular epithelial cells (TECs) play an
active role in renal inflammation. Previous studies have demon-
strated the capacity of TECs to modulate T-cell responses
both positively and negatively. Recently, new costimulatory
molecules [inducible T cell costimulator-L (ICOS-L) and B7-
H1] have been described, which appear to be involved in
peripheral T-cell activation.
Methods. We characterized expression and regulation of cos-
timulatory molecules on primary human TECs and the TEC line
human kidney-2 (HK-2) with reverse transcription-polymerase
chain reaction (RT-PCR) and flow cytometry. Immunohisto-
chemistry was performed on human kidney biopsies. The ca-
pacity of TECs to modulate T-cell activation was studied in
TEC/T-cell cultures.
Results. We demonstrate that TECs express ICOS-L and
B7-H1 in vitro and in vivo. Stimulation with interferon-c (IFN-
c) resulted in increased expression of B7-H1, whereas ICOS-
L expression was marginally increased upon stimulation with
CD40L, with no effect of interleukin (IL-1), IL-17, or tumor
necrosis factor-a (TNF-a). Furthermore, we show that TECs
are able to costimulate T cells that have received signal-1 using
aCD3 antibodies, inducing strong IL-10 production, which was
partially mediated by ICOS-L. In contrast, B7-H1 appeared to
be involved in inhibition of proliferation and cytokine synthe-
sis. In addition, TECs were able to alter the cytokine profile of
fully activated T cells, which were incubated with aCD3 and
aCD28 antibodies, resulting in low IFN-c and high IL-10 pro-
duction. This activity appeared to be independent of ICOS-L
and B7-H1.
Conclusion. Interaction of tubular epithelial cells and kidney
infiltrating T cells via ICOS-L and B7-H1 may change the bal-
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ance of positive and negative signals to the T cells, leading to
IL-10 production and limitation of local immune responses.
Interstitial infiltration and tubular injury is a hallmark
of renal allograft rejection and many renal inflamma-
tory diseases [1, 2]. Renal tubular epithelial cells (TECs)
are thought to play a central role in the local inflamma-
tory response via cytokine and chemokine production
[3]. Furthermore, TECs have been demonstrated to ex-
press major histocompatability complex (MHC) class I
and II molecules and also have the capacity to process
and present antigens in the context of MHC molecules
[4, 5]. Based on these observations, it has been postulated
that renal epithelial cells may function as nonprofessional
antigen-presenting cells (APCs) and thereby regulate the
local activation status of T cells [6, 7]. Some studies have
shown that presentation of foreign or alloantigens by
TECs may lead to T-cell activation [4, 8, 9], whereas other
studies have demonstrated that TECs can induce T-cell
hyporesponsiveness, suggesting a role for TECs in main-
taining peripheral tolerance to self antigens [10–13].
T-cell activation is the net result of stimulatory and
inhibitory costimulatory signals. The best characterized
costimulatory molecules are B7.1 (CD80) and B7.2
(CD86), which are predominantly expressed by profes-
sional APCs (dendritic cells and monocytes). Whether
tubular epithelial cells express B7.1 and B7.2 has been a
matter of debate [10, 13–16]. However, TECs were found
to express other accessory molecules, such as CD40, inter-
cellular adhesion molecule-1 (ICAM-1), and vascular cell
adhesion molecule-1 (VCAM-1), which are all involved
in T-cell activation [12, 17]. Importantly, it has been shown
that memory and effector T cells are less dependent on
costimulation than naive cells and can be activated by
professional and nonprofessional APCs [18].
In addition, new costimulatory molecules have been
identified, which are more broadly expressed and may
play a role in the regulation of peripheral T-cell activation
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by tissue cells. One of these molecules is inducible T-
cell cotimulator (ICOS) ligand (ICOS-L) (also termed
B7h, GL50, B7RP-1, and LICOS), which is expressed
in lymphoid (B, T, dendritic cells, monocytes) and non-
lymphoid tissue, including kidney [19, 20]. Interaction be-
tween ICOS-L and ICOS, which is expressed on activated
T cells, has been implicated in T-cell proliferation and
the regulation of cytokine production by effector T cells
[21, 22]. Another member of the B7 family that was re-
cently identified is B7-H1 (PD-L1). The receptor for B7-
H1 is programmed death-1 (PD-1). Some studies suggest
that B7-H1 is involved in inhibition of T-cell prolifera-
tion [23]. However, other studies have shown that B7-H1
can increase T-cell proliferation and cytokine production,
which was independent of PD-1, indicating the presence
of another, as yet unidentified receptor [24, 25]. Since B7-
H1 is also expressed in nonlymphoid tissues, B7-H1 was
suggested to play a role in peripheral tolerance [26, 27].
In the present study we have characterized the expres-
sion and regulation of B7.1 and B7.2 as well as the novel
B7 molecules ICOS-L and B7-H1 on human proximal
TECs. Furthermore, we investigated the role of these
costimulatory molecules in the capacity of TECs to mod-
ulate T-cell activation. We demonstrate that interaction
of TECs with T cells favors interleukin (IL)-10 produc-
tion and reduces interferon (IFN)-c production, indicat-
ing that TECs may alter the effector function of T cells
in renal inflammation.
METHODS
Cell culture
The immortalized renal proximal TEC line human
kidney-2 (HK-2) was kindly provided by M. Ryan, Uni-
versity College Dublin, Ireland [28]. Cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM)/HAM
F-12 (Bio-Whittaker, Walkersville, MD, USA) supple-
mented with insulin (5 lg/mL), transferrin (5 lg/mL),
selenium (5 ng/mL), hydrocortisone (36 ng/mL), tri-
iodothyronine (40 pg/mL), epidermal growth factor
(EGF) (10 ng/mL) (all from Sigma Chemical Co., St.
Louis, MO, USA) and 100 U/mL penicillin/100 lg/mL
streptomycin (Invitrogen, Paisley, UK). Primary human
proximal TECs (PTECs) were isolated from kidneys not
suitable for transplantation and from pretransplant biop-
sies and cultured as described [17]. The specific outgrowth
of PTECs was confirmed by morphologic appearance
and immunofluorescence staining (CD26-positive), as de-
scribed [29]. Generation of monocyte-derived immature
dendritic cells has been described previously [30].
Flow cytometry
Cells were harvested by brief trypsinization with 0.02%
(wt/vol) ethylenediaminetetraacetic acid (EDTA)/0.05%
(wt/vol) trypsin (Sigma Chemical Co.) to prevent pro-
teolysis of surface receptors. Cells were washed in
fluorescence-activated cell sorter (FACS) buffer [1%
bovine serum albumin (BSA), 1% decomplemented nor-
mal human serum and 0.02% sodium azide in phosphate-
buffered saline (PBS)]. FACS analysis was performed
using monoclonal antibody against CD40 (monoclonal
antibody 89), B7.1 (monoclonal antibody 104) [31], B7.2
(IT2.2) (Pharmingen, San Diego, CA, USA), ICOS-L
(HIL-131) [32], and B7-H1 (5H1) or an irrelevant mouse
IgG1 control antibody [33]. Staining was visualized with
goat anti-mouse Ig-PE (Dako, Glostrup, Denmark), as-
sessed for fluorescence using a FACScalibur and analyzed
with Cell Quest Pro software (Becton Dickinson, Moun-
tain View, CA, USA). In stimulation experiments, cells
were incubated for 48 hours with 5 ng/mL IL-1a, 100
ng/mL tumor necrosis factor-a (TNF-a), 50 ng/mL IL-
17, 100 ng/mL IFN-c (all from R&D Systems, Minneapo-
lis, MN, USA) or irradiated (80 Gy) CD40L-transfected
L cells [34] in a 1:1 ratio. To discriminate TECs from
L cells, the cells were incubated with 10 lg/mL digoxi-
genin (DIG)-labeled monoclonal antibody 89 (aCD40)
followed by aDIG-fluorescein isothiocyanate (FITC)
(Boehringer Mannheim, Mannheim, Germany). Acces-
sory molecule expression was calculated by the ratio of
mean fluorescence intensity (MFI) (i.e., the quotient of
MFI with and without specific antibody). Stimulation in-
dexes (SI) were calculated as follows: SI = MFI stimu-
lus/MFI untreated cells. The data were analyzed with a
paired Student t test.
Reverse transcription-polymerase chain reaction (RT-
PCR) for detection of B7.1, B7.2, ICOS-l, B7-H1, and
CD40 transcripts
Total RNA was isolated using RNAzolB (Campro,
Veenendaal, The Netherlands) according to manufac-
turer’s instructions. Optical density (OD) 260/280 ratios
were measured to determine the quantity and purity of
RNA preparations. Fixed amounts of total cellular RNA
(1 lg) were reverse transcribed into cDNA by oligo-dT
priming using Maloney-murine leukemia virus (M-MLV)
reverse transcriptase (Gibco/Life Technologies, Breda,
The Netherlands). Primer sequences for RT-PCR are
shown in Table 1. PCR was performed under standard
conditions [50 mmol/L KCl, 10 mmol/L Tris-HCl, pH
8.4, 0.06 mg/mL BSA, 1.5 mmol/L MgCl2, 0.25 mmol/L
deoxynucleosidetriphosphate (dNTP), 25 pmol of each
primer, 1 U of Taq polymerase] (Perkin Elmer, Norwalk,
CT, USA) for 35 cycles. PCR products were analyzed on
a 1% agarose gel containing ethidium bromide.
Immunohistochemistry
For detection of B7-H1 and ICOS-L in renal tis-
sue, we used samples from three normal kidneys not
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Table 1. Primer sequences
Sequence 5′-3′ bp Reference
B7.1 Forward CCTCTCCATTGTGATCCTGG 565 [55]
Reverse GGCGTACACTTTCCCTTCTC
B7.2 Forward GTATTTTGGCAGGACCAGGA 663 [55]
Reverse GCCGCTTCTTCTTCTTCCAT
ICOS-L Forward ACCATGCGGCTGGGCAGTC 420
Reverse GCACGCTGAAGTTTGCTGCC
B7-H1 Forward GTCACGGTTCCCAAGGACC 450
Reverse CAGATGACTTCGGCCTTGGG
CD40 Forward GCCTGGTCTCACCTGGCC 596 [56]
Reverse TCTCAGCCGATCCTGGGGACC
b-actin Forward CTACAATGAGCTGCGTGTGG 527 [57]
Reverse AAGGAAGGCTGGAAGAGTGC
ICOS-L is inducible T-cell costimulator ligand.
suitable for transplantation and two biopsies taken prior
to transplantation of the kidney. Cryostat sections of
3 lm were acetone fixed for 10 minutes at room tem-
perature. After washing and blocking endogenous per-
oxidase with 0.03% H2O2, sections were blocked for 20
minutes with 1% normal goat serum in PBS/1% BSA and
incubated for 45 minutes with HIL-131 (aICOS-L), 5H1
(aB7-H1), or without primary antibody (control). After
washing with PBS, sections were subsequently incubated
with goat-antimouse Ig-horseradish peroxidase (HRP)
(Dako), tyramide-FITC in tyramide buffer (NENTM)
(Life Science Products, Inc., Boston, MA, USA) and
rabbit-anti-FITC-HRP (Dako) for 60 minutes each. An-
tibody binding was visualized with Nova RED (Vector,
Brunschwig, Amsterdam, The Netherlands) as a sub-
strate. Slides were counterstained with hematoxylin and
eosin.
Mixed TECs/T-cell culture
T cells were isolated from peripheral blood from
healthy donors by sheep erythrocyte rosetting and in-
cubated with 0.5 lg/mL aCD3 antibody (CLB-T3/4.E)
or a combination of aCD3 and 0.1 lg/mL aCD28 anti-
body (CLB-CD28/1) to induce T-cell activation [35]. For
cocultures, 1.5 × 105 T cells were mixed with irradiated
(60 Gy) primary human TECs or the TEC-derived cell
line HK-2 in a ratio of 7.5:1. Cells were cultured in 96-
well flat-bottom culture plates (Costar, Badhoevedorp,
The Netherlands) in RPMI 1640 containing 10% heat-
inactivated fetal calf serum (FCS) (both from Gibco).
Cell proliferation was quantified by 6 hr incubation with
1 lCi (methyl-[3H]) thymidine (NENTM) (Life Science
Products, Inc.). Results are presented as the mean cpm
± SD obtained from triplicate cultures. Where indicated,
10 ng/mL IL-10 (R&D Systems) or 10 lg/mL neutralizing
anti-IL-10R antibody [36] were added to the cultures.
Cytokine production
The production of IFN-c and IL-10 in culture super-
natants was measured by enzyme-linked immunosorbent
assay (ELISA). The IFN-c ELISA was performed as pre-
viously described [37]. For detection of IL-10, the PeliPair
reagent set for human IL-10 (Sanquin, Amsterdam, The
Netherlands) was used according to manufacturer’s in-
structions.
Statistical analysis
Results are shown as mean ± SD from triplicate cul-
tures from representative experiments or as mean ± SEM
from composite experiments. Data from different exper-
iments were pooled and analyzed with a paired Student
t test. Results were considered significant if P < 0.05.
RESULTS
TECs express ICOS-L and B7-H1
Cell surface expression of costimulatory molecules on
primary TECs and the TEC-derived cell line HK-2 was
determined by FACS analysis. Immature dendritic cells
were used as a positive control. Both primary TECs and
HK-2 cells were found to express ICOS-L and B7-H1
(Fig. 1). Expression of B7.1 and B7.2 was readily detected
on immature dendritic cells, but was not detected on HK-
2 cells or primary TECs. To confirm these data, we an-
alyzed mRNA expression of costimulatory molecules in
seven primary TEC lines and in HK-2 cells (Fig. 2). CD40
is known to be expressed by cultured TECs [17] and was
used as a positive control for the mRNA quality. Compat-
ible with the FACS results, B7.1 and B7.2 mRNA was not
detected in primary TECs or HK-2. Furthermore, seven
or seven primary TECs were found to express mRNA for
ICOS-L, whereas five of seven primary TECs expressed
B7-H1 mRNA. Both ICOS-L and B7-H1 mRNA were
detected in HK-2. Immature dendritic cells expressed
mRNA for all costimulatory molecules investigated.
Regulation of ICOS-L and B7-H1 expression on TECs
Infiltrating monocytes and T cells supply the local en-
vironment with a variety of cytokines, including TNF-
a, IL-1, IFN-c, and IL-17. Furthermore, CD40-CD40L
interaction has been shown to activate TECs, leading
to increased cytokine and chemokine expression [17].
Therefore, we analyzed the effect of these signals on
ICOS-L and B7-H1 expression by TECs. None of the
cytokines tested were able to alter ICOS-L expression
by HK-2 cells (Fig. 3A). Only stimulation with CD40L
induced a marginal but significant (1.6 ± 0.08-fold) in-
crease in ICOS-L expression (Fig. 3A). In contrast, B7-
H1 expression on HK-2 cells was strongly increased upon
stimulation with IFN-c (2.4 ± 0.7-fold), but not with the
other cytokines or CD40L (Fig. 3B and C). As shown
in Figure 3C, the effect of IFN-c on B7-H1 expression
was even stronger in primary TECs (4.4 ± 0.6-fold).
Stimulation of TECs with cytokines or CD40L did not
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Fig. 1. Cell surface expression of costimu-
latory molecules by tubular epithelial cells
(TECs). Expression of CD40, B7.1, B7.2,
inducible T-cell costimulator ligand (ICOS-
L) and B7-H1 on the surface of immature
dendritic cells (immDC), the TEC-derived
cell line human kidney-2 (HK-2), and prox-
imal human TECs (PTECs) was determined
by fluorescence-activated cell sorter (FACS)
analysis. An irrelevant mouse IgG1 antibody
was used as isotype control.
result in the induction of B7.1 or B7.2 expression (data
not shown).
Expression of ICOS-L and B7-H1 in human renal tissue
To investigate whether TECs express ICOS-L and
B7-H1 in vivo, immunohistochemistry was performed on
normal human renal tissue obtained from kidneys not
suitable for transplantation due to anatomic reasons or
from pretransplant biopsies. Expression of ICOS-L was
detected on the majority of tubules, showing staining in
the cytosol and at the basolateral site of the tubules (Fig.
4C and D). This is also the site where infiltrating immune
cells will primarily encounter tubular cells after enter-
ing the tubulointerstitium. Furthermore, ICOS-L was de-
tected on endothelial cells and smooth muscle cells of the
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Fig. 2. mRNA expression of costimulatory
molecules by tubular epithelial cells (TECs).
Total RNA was isolated from proximal human
TECs (PTECs), human kidney-2 (HK-2) and
from immature dendritic cells (immDC) as a
positive control. Expression of B7.1, B7.2, in-
ducible T-cell costimulator ligand (ICOS-L),
B7-H1, and CD40 was determined by reverse
transcription-polymerase chain reaction (RT-
PCR). As a control, serial cDNA dilutions
(10−3, 10−4, and 10−5) were used to determine
the expression of b-actin.
large vessels (Fig. 4C). B7-H1 expression was detected on
approximately 30% of the tubules (Fig. 4E and F), which
might reflect the local activation status of the tubuli. In
addition, positive staining was observed throughout the
entire glomerulus (Fig. 4E), whereas the vessels were neg-
ative for B7-H1.
TECs induce IL-10 production by T cells
Next, we examined the role of ICOS-L and B7-H1 on
TECs in their capacity to provide costimulatory signals
to T cells, as assessed by T-cell proliferation and cytokine
production. Therefore, we used a previously described
model, in which peripheral blood T cells were triggered
with an aCD3 antibody (IgE) which does not induce ac-
tivation or proliferation unless a costimulatory signal is
provided during culture [35, 38]. In line with this model,
incubation of T cells with aCD3 did not induce T-cell
proliferation, which was measured by thymidine incor-
poration at day 6 of culture (Fig. 5A). As expected, com-
bination of aCD3/aCD28 antibodies resulted in strong
T-cell proliferation (Fig. 5A) and high levels of IFN-c
were produced (Fig. 5B), ranging from 17.3 ng/mL to
36.9 ng/mL in different experiments. Under the condi-
tions of aCD3/aCD28 costimulation also production of
IL-10 was induced (Fig. 5C), ranging from 82 pg/mL to
1055 pg/mL.
To determine the costimulatory signals of TECs, T cells
were cultured with aCD3 in the presence of irradiated
HK-2 cells at a ratio of 7.5:1. Radiation of HK-2 cells
did not alter the expression of costimulatory molecules
as determined by FACS analysis (data not shown). No
T-cell proliferation was induced upon cocultures of HK-
2 and T cells at day 6 after start of the cultures either
with or without aCD3 (Fig. 5A). Strikingly, coculture of
T cells and HK-2 cells in the presence of aCD3 antibody
induced strong IL-10 production in the absence of IFN-c
(Fig. 5B and C). Induction of IL-10 production by HK-2
cells was on average 93 (± 26) pg/mL and was significantly
increased compared to T cells stimulated with aCD3 an-
tibody only (8 ± 5 pg/mL) (P < 0.005).
IL-10 production is partially dependent on ICOS-L
To determine the kinetics of IL-10 induction, IL-10 was
measured at days 1 to 6 after start of the cocultures. IL-10
production reached a maximum at day 2 (Fig. 6A), with
a mean production of 491 ± 115 ng/mL (Fig. 6C). IFN-
c was not detected at any time point (data not shown).
Also coculture of T cells with primary human TECs in
the presence of aCD3 resulted in high IL-10 production
at day 2 (Fig. 6B) without an effect on T-cell proliferation
and no detectable IFN-c production (data not shown).
Induction of IL-10 production by primary TECs from
three different donors was comparable to the HK-2 cell
line (Fig. 6B and C).
To determine the role of B7-H1 and ICOS-L in IL-
10 production, we administered blocking antibodies (10
lg/mL) to the HK-2/T-cell cocultures and measured [3H]
incorporation and IL-10 production at day 2 of culture.
Although no proliferation was observed at day 6, we de-
tected a low level of [3H] incorporation at day 2 when T
cells were incubated with aCD3, which was significantly
increased in the presence of HK-2 cells (mean fold in-
crease 12.0 ± 3.0) (P < 0.05) (Fig. 7A). Induction of
IL-10 production was strictly dependent on the presence
of HK-2 cells (Fig. 7B). Blocking ICOS-L resulted in a
significant 50.1% (± 4.6) decrease in proliferation (P =
0.01) and a concomittant decrease in IL-10 production
(29.4% ± 5.3%) (P < 0.05). Blocking B7-H1 resulted in
increased proliferation in three of five experiments, but
this was not statistically significant (P < 0.168). IL-10 pro-
duction was increased in five of five experiments, with on
average 1.8-fold increase (± 0.17) (P < 0.05). Combina-
tion of aICOS-L and aB7-H1 antibodies neutralized the
modulating effect of these antibodies on proliferation and
IL-10 production (data not shown). Taken together, these
2096 de Haij et al: Renal TECs and T-cell responses via ICOS-L and B7-H1
4
3
2
1
0
St
im
ul
at
io
n 
in
de
x
4
3
2
1
0
St
im
ul
at
io
n 
in
de
x
Co
nt
ro
l
IL
-1
TN
F-
a
IL
-1
7
IF
N
-g
CD
40
L
Co
nt
ro
l
IL
-1
TN
F-
a
IL
-1
7
IF
N
-g
CD
40
L
A
B
IFN-γ
ICOS-L B7-H1
0
10
0
0
10
0
0
10
0
0
10
0
100 101 102 103 104 100 101 102 103 104
100 101 102 103 104 100 101 102 103 104
*
*
C
HK-2
PTEC
Fig. 3. Regulation of inducible T-cell costimulator ligand (ICOS-L)
and B7-H1 expression by tubular epithelial cells (TECs). (A and B) Hu-
man kidney-2 (HK-2) cells were stimulated for 48 hours with interleukin
(IL)-1 (5 ng/mL), tumor necrosis factor-a (TNF-a) (100 ng/mL), IL-17
(50 ng/mL), interferon (IFN)-c (100 ng/mL), or CD40L-transfected L
cells in a 1:1 ratio. Nontransfected L cells were used as a negative con-
trol for CD40L stimulation. Protein expression of ICOS-L (A) and B7-
H1 (B) was measured by comparing relative fluorescence-activated cell
sorter (FACS) intensities as described in the Methods section. Data are
presented as mean stimulation index (± SD) of three separate exper-
iments. ∗P < 0.01. (C) Representative experiments showing the effect
of IFN-c (filled histograms) on ICOS-L and B7-H1 expression by HK-2
cells and primary TECs.
data suggest that the outcome of the T-cell response is
dependent on the interplay between ICOS-L and B7-H1.
TECs modulate the cytokine profile of activated T cells
Based on the observations described above, we inves-
tigated whether TECs may also modulate the response
of fully activated T cells. Therefore, T cells were incu-
bated with aCD3 and aCD28 antibodies and cocultured
with irradiated HK-2 cells (Fig. 8). As expected, T cells
activated via a combination of aCD3 and aCD28 showed
a strong T-cell proliferation both at day 2 and at day 6.
No difference in T-cell proliferation was observed at day
2 in the presence or absence of TECs, whereas at day
6, T-cell proliferation was significantly decreased upon
coculture with TECs, with a mean inhibition of 30.2%
± 9.2% in seven independent experiments (P < 0.05)
(Fig. 8A). IFN-c production initially increased in T cells
cocultured with TECs. However, in five of seven experi-
ments, production of IFN-c at day 6 was strongly reduced
(83.0% ± 1.8%) (P < 0.05) compared to T cells incu-
bated with aCD3/aCD28 only (Fig. 8B). Importantly, T
cells incubated in the presence of TECs produced very
high amounts of IL-10 compared to T cells incubated
with aCD3/aCD28 only (Fig. 8C). At day 2, IL-10 pro-
duction by aCD3/aCD28-stimulated T cells ranged from
98 pg/mL to 2169 pg/mL, which increased to 513 pg/mL
to 6804 pg/mL in the presence of HK-2, with a mean fold
stimulation of 6.6 ± 0.9 (P < 0.05). Similar results were
obtained with primary human TECs (data not shown).
Administration of blocking antibodies to B7-H1 and
ICOS-L had no significant effect on proliferation and
IFN-c production by T cells activated with aCD3/aCD28
antibodies (data not shown). Furthermore, the high IL-
10 production by T cells cocultured with HK-2 cells and
a combination of aCD3/aCD28 antibodies was not sig-
nificantly altered in the presence of blocking antibodies
to ICOS-L, B7-H1 (Fig. 9A), or both (data not shown).
IL-10 is known to inhibit T cell proliferation and IFN-
c production [39, 40]. Administration of a neutralizing
anti-IL-10R antibody was able to prevent the decrease in
T-cell proliferation induced by exogenously added IL-10
(10 ng/mL). However, the same antibody showed no ef-
fect on T-cell proliferation (Fig. 9B) or IFN-c production
(not shown) in HK-2 cocultures. This suggests that the rel-
atively late (day 6) block in proliferation in the presence
of HK-2 cells was not mediated by endogenous IL-10 pro-
duction. The data depicted in Figure 8 indicate acceler-
ated T-cell activation in the presence of HK-2 cells, which
may result in increased consumption of medium nutri-
ents. To investigate this possibility, aCD3/aCD28 stimu-
lated T cells were cultured with HK-2 cells at different
ratios. As demonstrated in Figure 9C, lowering the T-cell
number shifted the peak in proliferation from day 2 to
day 5 (half the amount of T cells) to day 7 (one fourth
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Fig. 4. Expression of inducible T-cell costim-
ulator ligand (ICOS-L) and B7-H1 by renal
tubular epithelial cells (TECs) in vivo. Normal
renal tissue sections were stained for ICOS-
L and B7-H1 as described in the Methods
section. (A and B) Negative control (staining
without primary antibody). (C and D) ICOS-
L. (E and F) B7-H1. Shown are 100-fold (A,
C, and E) and 400-fold (B, D, and F) magnifi-
cations. Arrows indicate ICOS-L and B7-H1
staining at the basal site of renal TECs.
the amount of T cells). Therefore, we cannot exclude that
the decreased T-cell proliferation at day 6 might at least
in part be due to exhaustion of the culture medium.
DISCUSSION
T-cell infiltration is a hallmark of many inflammatory
renal diseases. Previous studies have demonstrated the
capacity of TECs to modulate T-cell responses both pos-
itively and negatively, but the molecular mechanisms are
largely unknown. In the present study we demonstrate
that human TECs express the novel B7 family mem-
bers ICOS-L and B7-H1. Coculture experiments showed
that TECs-T-cell interaction results in T cells with a low-
proliferating, IL-10–producing phenotype, which is par-
tially regulated by ICOS-L and B7-H1. Furthermore,
TECs were able to promote IL-10 production by fully
activated T cells, which was accompanied by inhibition
of proliferation and IFN-c production, independent of
ICOS-L and B7-H1.
For other nonprofessional APCs, such as endothelial
cells, keratinocytes, and fibroblasts, lack of B7.1 and B7.2
expression was suggested to be responsible for the lim-
ited capacity to induce T-cell activation [32, 41, 42]. Al-
though it was suggested that expression of B7.1 and B7.2
can be induced in TECs [14, 15], we and others [10, 13,
16] did not detect B7.1 and B7.2 expression on either
resting or activated primary human TECs as well as the
TEC-derived cell line HK-2. Recently, novel costimula-
tory molecules have been described, such as ICOS-L and
B7-H1, which are more broadly expressed and appear to
be involved in peripheral T-cell activation. Expression of
ICOS-L has been demonstrated on human umbilical vein
endothelial cells (HUVEC), which was further increased
upon stimulation with lipopolysaccharide (LPS), CD40,
TNF-a, and IL-1 [32]. Furthermore, ICOS-L expression
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Fig. 5. Tubular epithelial cells (TECs) induce interleukin (IL)-10 pro-
duction without an effect on proliferation and interferon (IFN)-c. Pu-
rified T cells were incubated with 0.5 lg/mL aCD3 antibody or with
a combination of aCD3 and aCD28 (0.1 lg/mL) as a positive control
for T-cell activation. For cocultures, T cells were mixed with irradiated
human kidney-2 (HK-2) cells at a ratio of 7.5:1. T-cell proliferation was
determined by [3H] incorporation at day 6 after start of the cocultures
(A). Culture supernatants were harvested for detection of IFN-c (B)
and IL-10 (C) by enzyme-linked immunosorbent assay (ELISA). Data
are shown as mean ± SD from triplicate wells. One representative of
seven independent experiments is shown.
was previously demonstrated on murine TECs and HK-2
cells [43]. We now extend these findings and show expres-
sion of ICOS-L on primary human TECs and HK-2 cells.
This expression was not increased after stimulation with
IL-1, IL-17, IFN-c, or TNF-a, and was only increased af-
ter CD40L stimulation, even though all stimuli strongly
induced IL-6 production by TECs (data not shown). In
addition, we observed constitutive B7-H1 expression on
HK-2 cells and most of the primary human TEC lines.
Expression of B7-H1 was strongly increased upon stimu-
lation with IFN-c, as has been described for endothelial
cells, keratinocytes, monocytes, and dendritic cells [23, 41,
44].
Knowing that TECs express ICOS-L and B7-H1, we
determined the role of these molecules in the transmis-
sion of costimulatory signals by TECs to T cells. Inter-
action with TECs resulted in T cells with the capacity
to produce IL-10 with a maximum at day 2, which was
accompanied by a temporary induction of [3H] incor-
poration. Blocking studies demonstrated that IL-10 pro-
duction and the low level of proliferation were partially
mediated by ICOS-L. Although some studies suggest that
B7-H1 can increase T-cell proliferation associated with an
increase in IL-10 production [24], blockade of B7-H1 re-
sulted in increased proliferation and IL-10 production,
consistent with an inhibitory role of this molecule [23].
Previous studies have demonstrated that IFN-c–treated
TECs can induce T-cell hyporesponsiveness [13]. Our re-
sults suggest that induction of B7-H1 expression by IFN-c
might be a mechanism involved.
Using the same T-cell activation model, it has been
demonstrated that melanoma cells induce T-cell prolif-
eration in a 3-day coculture, which was dependent on
CD40 expression [45]. Furthermore, it has been shown
that CD40 is capable of stimulating T-cell proliferation
and favors IL-10 production [46]. As the TECs that we
used in our study expressed high levels of CD40, CD40-
CD40L interaction may also contribute to the induction
of proliferation and IL-10 production, either directly or
via increased expression of ICOS-L. The absence of pro-
liferation at day 6 is most likely due to low IL-2 pro-
duction, as ICOS-L and CD40 are weak inducers of IL-2
production by T cells [21].
Under inflammatory conditions, TECs are most likely
to interact with recently activated T cells that were
primed in lymph nodes. Furthermore, T cells might be-
come activated locally via infiltrating professional APCs
[47]. Therefore, we examined whether TECs are able to
modulate the activation of T cells that were simultane-
ously triggered via CD28. Both primary human TECs and
the cell line HK-2 inhibited proliferation of fully activated
T cells. B7-H1 has been shown to inhibit T cell prolifer-
ation by inducing cell cycle arrest [23]. However, we did
not observe an increased number of T cells in the G0/G1
phase as measured by propidium iodide staining (data
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Fig. 6. Primary tubular epithelial cells
(TECs) induce interleukin (IL)-10 produc-
tion by T cells. (A) T cells were incubated with
aCD3 in the presence or absence of human
kidney-2 (HK-2) cells. Culture supernatants
were harvested at days 1 to 6 after start
of the cultures and IL-10 production was
measured by enzyme-linked immunosorbent
assay (ELISA). One representative of three
independent experiments is shown. (B)
Similar experiments as described (A) were
performed with three different proximal
TEC lines (PTEC1 to PTEC3). Supernatants
were harvested at day 2. (C) Data from
nine different experiments with HK-2 cells,
analyzed for IL-10 production at day 2 after
start of the cocultures, were pooled and
analyzed with a paired Student t test. ∗∗∗P <
0.005. Results are presented as mean ± SEM.
not shown). Furthermore, administration of a blocking
B7-H1 antibody had no effect. However, it should be
noted that the antibody we used (5H1) was suggested to
block binding of B7-H1 to an as yet unidentified non-PD-
1 receptor [25, 33]. Additional studies, including specific
blockade of PD-1-B7-H1 interaction, are required to give
more insight in the role of B7-H1 in TEC/T-cell interac-
tion.
In the presence of TECs, fully activated T cells also
displayed a different cytokine profile, characterized by
low IFN-c and high IL-10 production. Although differ-
ential effects of B7-H1 on IFN-c and IL-10 production
have been described [41, 44], using the 5H1 antibody, we
found no effect of B7-H1 on IL-10 or IFN-c production.
Similarly, while ICOS-L is known to have a profound ef-
fect on cytokine production, particularly IL-10 [22, 32],
blocking ICOS-L was unable to reverse the cytokine pro-
file. Furthermore, endogenous IL-10 production was not
involved in the inhibition of proliferation and IFN-c pro-
duction. Taken together, signals via ICOS-L and B7-H1
appear to regulate TEC-induced IL-10 production by T-
cell receptor (TCR)–triggered T cells, but are most likely
overruled by additional signals, including CD28, in the
response of fully activated T cells. In contrast to our re-
sults, a study with murine TECs has demonstrated that
ICOS-L may have a down-modulating role on T-cell ac-
tivation [43]. In this study, blocking ICOS-L enhanced
IL-2 production by HEL (henn egg lysozy)–specific T-
cell hybridomas after antigen presentation by TECs. In
our study, we have investigated the capacity of TECs to
transmit a costimulatory signal to T cells bypassing the
antigen specificity of the response, which might explain
this contradiction.
The presence of tubulitis is one of the major diagnostic
criteria for scoring rejection in the widely accepted Banff
classification system for allograft rejection [48]. However,
by taking protocol biopsies it has been recently demon-
strated that renal transplant patients on low-level im-
munosuppression did not develop acute rejection despite
the continuous presence of a low-grade T-cell infiltrate
and tubulitis [49]. These results suggest a role for TEC/T-
cell interaction in the down-modulation of the local T-cell
response. As IL-10 is a suppressor of T-cell proliferation
and cytokine synthesis and functions to limit or termi-
nate inflammatory responses [39, 40], our in vitro results
seem compatible with this hypothesis. Furthermore, we
demonstrate expression of B7-H1 and ICOS-L in tubu-
lar epithelial cells in tissue sections of normal human
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Fig. 7. Role for inducible T-cell costimulator ligand (ICOS-L) and B7-
H1 in tubular epithelial cell (TEC)/T-cell interaction. T cells were cul-
tured with aCD3 and human kidney-2 (HK-2) cells in the presence
of blocking aICOS-L and aB7-H1 antibodies or an irrelevant control
antibody (10 lg/mL). T-cell proliferation (A) and interleukin (IL)-10
production (B) were measured at day 2. One representative of five in-
dependent experiments is shown.
kidney in vivo. These results support a model in which
parenchymal cells may have an important role in the
regulation of the immune response, maintaining toler-
ance in healthy conditions and determining the effector
type response during inflammation [50, 51]. In addition
to ICOS-L and B7-H1, other B7-like molecules (B7-H3
and B7-H4/B7S1) have recently been identified, which
are also expressed in nonlymphoid tissues, including the
kidney [52–54]. Although expression of these molecules
on TECs remains to be determined, they might also play
a role in modulation of the local immune response.
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CONCLUSION
Interaction of TECs and T cells may alter the balance
of positive and negative signals to the T cells. One of the
consequences of this interaction seems to be the devel-
opment of IL-10 producing T cells, a process that might
aid in limiting or attenuating local T-cell responses. Our
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results provide new insight in the role of resident cells in
the regulation of peripheral immune responses.
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